U.S. Smart Patient Monitoring Devices Market: $48B by 2035

Market Outlook

By 2035, the U.S. Smart Patient Monitoring Devices Market is expected to reach approximately USD 48.00 billion, growing at a CAGR of 12.60% during the forecast period 2026–2035. The market was valued at USD 14.65 billion in 2025, with historical analysis from 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. smart patient monitoring devices industry is entering a structurally different growth cycle from the conventional bedside monitoring market. The category now combines connected multiparameter monitors, wearable biosensors, ambulatory cardiac devices, continuous glucose monitoring systems, smart respiratory monitors, implantable sensors, software-assisted alarm management, and remote monitoring peripherals that transmit clinically actionable data into care-team workflows. The defining feature is not connectivity alone. A device must produce reliable physiologic information, support timely clinical interpretation, and contribute to a monitored care pathway in a hospital, outpatient facility, post-acute setting, or patient home.

Demand is supported by an unusually large addressable clinical population. In 2023, approximately 194 million U.S. adults reported at least one chronic condition and about 130 million reported multiple chronic conditions. Nearly 120 million adults have hypertension, more than 40 million people have diabetes, and the population age 65 and older reached roughly 61.2 million in 2024. These populations require repeated measurement of blood pressure, glucose, heart rhythm, oxygen saturation, respiratory rate, temperature, weight, activity, sleep, and other physiologic indicators. Smart monitoring converts those measurements from isolated observations into continuous or longitudinal data that can support earlier intervention.

The historical market expanded from an estimated USD 8.56 billion in 2021 to USD 12.63 billion in 2024. Growth during this period was driven by hospital modernization, rapid adoption of continuous glucose monitoring, expansion of ambulatory cardiac monitoring, pandemic-era investment in virtual care, and rising payer interest in remote physiologic monitoring. The market reached USD 14.65 billion in 2025 as health systems increased investment in wireless surveillance, enterprise telemetry, hospital-at-home infrastructure, connected chronic disease programs, and devices designed to reduce unrecognized deterioration outside intensive care units.

The forecast assumes that the market will reach approximately USD 20.91 billion by 2028 and USD 26.52 billion by 2030 before reaching USD 48.00 billion in 2035. This expansion will not be evenly distributed. The fastest value creation will occur in wearable continuous monitoring, AI-assisted deterioration detection, connected diabetes management, ambulatory cardiac surveillance, smart home monitoring, and enterprise platforms that integrate data across bedside, transport, virtual ward, and home settings. Conventional spot-check devices will remain important but will grow more slowly unless manufacturers add connectivity, automated documentation, and workflow integration.

Introduction

According to the U.S. Smart Patient Monitoring Devices Market Report, the market sits at the intersection of medical devices, clinical informatics, chronic disease management, hospital operations, and reimbursement-enabled virtual care. U.S. providers are no longer evaluating monitoring solely as a hardware purchase. They are evaluating the full operating model: sensor accuracy, alarm burden, data latency, integration with the electronic health record, clinician response protocols, cybersecurity, patient adherence, consumable cost, technical support, and the measurable effect on length of stay, readmissions, nursing productivity, and avoidable escalation.

For market sizing purposes, smart patient monitoring devices include FDA-regulated or clinically deployed connected devices that collect and transmit physiologic data for professional interpretation or treatment management. The scope includes smart bedside and transport monitors, wearable patches and biosensors, remote blood pressure and pulse oximetry devices, mobile cardiac telemetry, continuous glucose monitors, smart respiratory monitoring, connected weight scales, implantable monitoring sensors, and related device-level software. Consumer wellness products without a defined clinical monitoring pathway are excluded, as are stand-alone telehealth consultation platforms, electronic health records, and general analytics products that do not depend on a monitoring device.

The U.S. care infrastructure provides a large installed base for adoption. The country has about 6,100 hospitals, more than 907,000 staffed hospital beds, and approximately 35.7 million annual hospital admissions. Certified electronic health record adoption is effectively universal among non-federal acute care hospitals and is above 90% among office-based physicians. This digital foundation reduces one of the historical barriers to connected monitoring because hospitals and physician groups can increasingly route device data into existing patient records, command centers, and clinical communication systems.

The market is also reinforced by payment and care-delivery changes. Medicare remote patient monitoring payments exceeded USD 500 million in 2024, and nearly one million Medicare enrollees received remote monitoring services. The Acute Hospital Care at Home initiative had 364 approved hospital billing entities across 136 health systems in 37 states by July 2026. These programs do not guarantee device adoption, but they establish operational pathways in which connected measurement becomes a required component of care. At the same time, increased federal oversight of remote monitoring billing is pushing buyers toward devices and programs with stronger documentation, patient engagement, and clinical accountability.

From 2026 to 2035, the central strategic shift will be from device-by-device procurement to longitudinal monitoring architecture. Health systems will increasingly want one operating model that can follow the patient from emergency department triage to inpatient care, procedural recovery, discharge, virtual ward management, and chronic follow-up. Manufacturers that can support interoperable data, enterprise cybersecurity, flexible sensor configurations, and service-line-specific analytics will be better positioned than suppliers offering isolated devices with closed data environments.

Key Market Drivers: What’s Fueling the U.S. Smart Patient Monitoring Devices Market Boom?

The first major driver is the scale of chronic disease and multimorbidity in the United States. Three in four adults report at least one chronic condition, and more than half report two or more. Hypertension affects nearly half of U.S. adults, yet only a minority achieve control. Diabetes affects more than 40 million people, while prediabetes affects more than 115 million adults. These conditions create recurring demand for blood pressure monitoring, continuous glucose sensing, weight surveillance, pulse oximetry, rhythm monitoring, and adherence-support technologies. The economic opportunity is strongest when monitoring is tied to a defined intervention pathway rather than passive data collection.

A second driver is the movement of monitoring beyond high-acuity beds. Traditional continuous monitoring was concentrated in intensive care, operating rooms, and step-down units. U.S. hospitals are now extending surveillance to medical-surgical floors, emergency department boarding areas, procedural recovery, rehabilitation units, and selected home-based episodes. The business case is driven by earlier detection of deterioration, fewer unplanned transfers, faster recognition of respiratory compromise, and improved visibility when nurse staffing is constrained. Wireless systems that allow ambulation while preserving continuous measurement are especially attractive because they support mobility protocols and reduce the operational friction of tethered devices.

A third driver is the maturation of remote patient monitoring reimbursement and operating models. Medicare payment for remote physiologic monitoring created a recurring revenue pathway for connected devices, setup, data transmission, and clinical management. Utilization has expanded rapidly since 2019, but scrutiny has also increased. This is changing vendor selection. Physician groups and health systems are prioritizing platforms that can document patient consent, device provisioning, transmission days, clinical review, treatment changes, and time spent. The market is therefore shifting away from low-engagement device distribution toward clinically managed programs with measurable outcomes.

A fourth driver is hospital labor economics. Monitoring technology is increasingly evaluated as a workforce tool because U.S. hospitals face persistent nursing shortages, high overtime expense, and uneven access to experienced telemetry staff. Central monitoring units, virtual nursing, alarm prioritization, automated charting, and mobile clinician notification can help redistribute work. The strongest systems do not claim to replace bedside staff; they reduce repetitive measurement, limit non-actionable alarms, and direct attention to patients whose trajectories are changing. Procurement committees are more receptive when vendors quantify the effect on documentation time, rounding efficiency, patient throughput, and escalation response.

A fifth driver is the aging population and growth of care outside traditional hospitals. The 65-and-older population has grown faster than the overall population, and all baby boomers will be at least 65 by 2030. Older adults have higher rates of hypertension, diabetes, atrial fibrillation, heart failure, chronic obstructive pulmonary disease, sleep disorders, and fall risk. They also move frequently among hospitals, skilled nursing facilities, home health, specialist practices, and family caregiving environments. Smart monitoring devices that are simple to use, require minimal charging, support caregiver access, and transmit data reliably are well aligned with this demographic shift.

A sixth driver is consumer familiarity with connected health data. Continuous glucose monitoring, smartwatch ECG, home pulse oximetry, connected blood pressure measurement, and app-based symptom tracking have normalized the concept of continuous health information. Clinical devices benefit from this familiarity, but medical-grade adoption depends on greater rigor. Providers need validated accuracy, standardized data, identity management, device assignment controls, and clear thresholds for escalation. Manufacturers that translate consumer-grade usability into regulated, clinically governed products can expand adherence without compromising trust.

A seventh driver is stronger interoperability infrastructure. Nearly all U.S. hospitals use certified electronic health records, and a growing share use the same EHR developer across inpatient and outpatient environments. This makes it more feasible to integrate monitoring data into flowsheets, clinician inboxes, population health dashboards, and command centers. Integration remains expensive and technically complex, but interoperability is now a competitive requirement rather than a premium feature. Devices that rely on proprietary portals alone face resistance because clinicians are already burdened by fragmented applications and duplicate documentation.

An eighth driver is the expanding role of data in value-based care. Accountable care organizations, Medicare Advantage plans, health systems under readmission pressure, and specialty groups increasingly need objective data between visits. Connected monitoring can support earlier medication adjustment, post-discharge surveillance, risk stratification, and documentation of treatment response. The most defensible programs focus on populations where timely measurement changes care, such as uncontrolled hypertension, insulin-treated diabetes, heart failure, post-operative recovery, chronic respiratory disease, and arrhythmia evaluation.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. smart patient monitoring devices market is moving from basic data capture toward context-aware surveillance. New systems combine multiple physiologic signals, patient-specific baselines, mobility information, and trend analysis to identify deterioration before a single vital sign crosses a static threshold. This approach is strategically important because traditional alarm settings can generate high volumes of non-actionable notifications. Manufacturers are investing in algorithms that prioritize rate of change, signal quality, and multi-parameter patterns while preserving clinician control over alert rules.

Wearable biosensors are one of the most important innovation areas. Thin patches, wireless chest sensors, smart watches with medical connectivity, and compact body-worn monitors can track heart rate, respiratory rate, oxygen saturation, temperature, posture, activity, ECG, and other signals without confining patients to a bed. In hospitals, these devices support monitoring on lower-acuity floors and during ambulation. In the home, they enable virtual wards and post-discharge surveillance. Commercial success depends on skin tolerance, battery life, data continuity, adhesive performance, patient comfort, and the ability to distinguish true physiologic change from motion artifact.

Continuous glucose monitoring is expanding the definition of patient monitoring beyond traditional hospital vital signs. The United States now includes prescription and over-the-counter CGM pathways, longer-wear sensors, integration with automated insulin delivery, and app-based trend interpretation. The clinical market remains anchored in diabetes management, but broader access is creating new channels through primary care, employer health, pharmacies, and consumer-directed metabolic monitoring. The growth opportunity is substantial, although manufacturers must manage reimbursement variability, sensor affordability, data overload, and the risk that non-clinical use may be confused with disease management.

Smart cardiac monitoring is advancing through smaller patches, longer recording periods, improved arrhythmia algorithms, mobile cardiac telemetry, and connected implantable devices. The value proposition is shifting from simply recording ECG to accelerating diagnostic resolution. Cardiology groups want systems that reduce analyzable noise, prioritize urgent findings, integrate with the clinical record, and support efficient interpretation at scale. The January 2026 clearance of an updated BodyGuardian remote monitoring system and the continuing expansion of sensor-based device clearances illustrate the pace of innovation in ambulatory cardiac surveillance.

Hospital monitoring platforms are also becoming more mobile and enterprise-oriented. Wireless systems can now follow patients across the emergency department, inpatient floor, transport corridor, diagnostic department, and recovery area without repeatedly disconnecting and reconnecting equipment. New telemetry platforms are designed to scale monitoring capacity during census surges, while centralized dashboards help hospitals manage patients across multiple units. The purchasing decision is increasingly influenced by the platform’s ability to standardize workflows across facilities and reduce retraining when health systems consolidate.

Alarm management and predictive analytics represent another major innovation layer. Manufacturers are developing tools that suppress artifact, group related events, rank patient risk, and route alerts to the appropriate clinician. The objective is not maximum alarm sensitivity at any cost. It is a better balance between missed deterioration and excessive notification. Health systems are demanding prospective validation, subgroup performance data, transparent escalation logic, and post-deployment monitoring because algorithm behavior can vary across patient populations, clinical environments, and sensor configurations.

Connectivity and cybersecurity are becoming product-design priorities. Smart monitoring devices may communicate through Bluetooth, Wi-Fi, cellular networks, gateways, mobile applications, and cloud services. Each connection introduces operational and security requirements. U.S. buyers increasingly require software bills of materials, vulnerability disclosure processes, patching commitments, network segmentation guidance, encryption, authentication, and clearly defined support periods. FDA expectations for connected-device cybersecurity and AI lifecycle management are raising the cost of development but also rewarding manufacturers with mature quality systems.

Manufacturers are also raising the bar through service design. Device performance alone does not determine whether a remote monitoring program succeeds. Vendors are adding patient onboarding, multilingual education, logistics, replacement management, adherence outreach, clinical dashboards, integration services, and reimbursement support. These services can increase the total contract value but also improve retention and outcomes. The most successful suppliers will combine reliable hardware with a disciplined implementation model that defines who reviews data, how quickly alerts are handled, and what action follows an abnormal reading.

Segmentation Insights

The U.S. Smart Patient Monitoring Devices Market is segmented on the basis of device type, monitoring modality, application, end user, and region. The segmentation reflects how U.S. buyers evaluate the market: the physiologic function of the device, the frequency and location of monitoring, the clinical condition being managed, the care setting responsible for intervention, and the regional structure of provider demand.

By Device Type

Wearable biosensors and smart patches represented an estimated USD 3.66 billion in 2025 and form the largest device-type subsegment. Products include ECG patches, wireless vital-sign sensors, body-worn multiparameter monitors, smart medical watches, temperature patches, and motion-enabled recovery sensors. Adoption is strongest where mobility and continuous observation are both important. Hospitals use wearables to extend surveillance to lower-acuity beds, while home-care programs use them to monitor post-operative recovery, respiratory status, and cardiac rhythm. The segment is expected to grow above the market average because it supports both facility-based and home-based workflows.
Smart multiparameter, bedside, and transport monitors generated approximately USD 3.22 billion in 2025. This category includes high-acuity monitors, compact vital-sign monitors, wireless transport systems, central stations, and device-level software that manages alarms and connectivity. Revenue is supported by replacement cycles, health-system standardization, new hospital construction, and expansion of monitored capacity. Growth is slower than wearable monitoring but remains durable because intensive care, operating rooms, emergency care, and procedural environments require dependable continuous monitoring. Premium demand is shifting toward modular systems that can scale across acuity levels.
Smart glucose monitoring systems accounted for an estimated USD 2.93 billion in 2025. The subsegment includes continuous glucose monitors, connected glucose meters, transmitters, receivers, and device-linked applications used for clinical management. Growth is supported by the large diabetes population, expanding CGM eligibility, pharmacy distribution, integration with automated insulin delivery, and consumer awareness. The U.S. market is moving toward longer sensor wear, simpler insertion, fewer calibration requirements, and more automated interpretation. Over-the-counter pathways are expanding awareness, while prescription CGM remains the principal clinical revenue pool.
Connected cardiac monitoring devices represented approximately USD 2.49 billion in 2025. This segment includes mobile cardiac telemetry, Holter systems, event monitors, ECG patches, smart handheld ECG devices, implantable loop recorders, and connected rhythm-management follow-up devices. Demand is driven by atrial fibrillation, syncope evaluation, post-ablation monitoring, cryptogenic stroke workups, and the need to diagnose intermittent arrhythmias. The competitive focus is on signal quality, wear duration, rapid report turnaround, algorithm-assisted analysis, and cardiology workflow efficiency.
Smart respiratory and other specialty monitoring devices generated approximately USD 2.35 billion in 2025. Products include connected pulse oximeters, capnography devices, respiratory rate monitors, spirometers, sleep-monitoring systems, cerebral oximetry, maternal-fetal monitoring, neurological sensors, and connected weight or fluid-status devices. Respiratory monitoring benefits from chronic obstructive pulmonary disease, sleep apnea, opioid safety, and post-acute surveillance. Specialty monitoring is fragmented but strategically attractive because clinical differentiation can support premium pricing.

By Monitoring Modality

Continuous non-invasive monitoring was the largest modality, valued at approximately USD 5.13 billion in 2025. It includes continuous ECG, oxygen saturation, respiratory rate, temperature, blood pressure trending, glucose monitoring, and multi-signal wearable surveillance. Continuous monitoring creates value when clinicians need early warning rather than periodic confirmation. Adoption is expanding from critical care into medical-surgical units, emergency observation, virtual wards, and post-discharge pathways. The commercial challenge is to maintain reliable signal quality while limiting alarm fatigue and unnecessary clinician workload.
Remote home-based monitoring generated an estimated USD 3.81 billion in 2025 and is expected to be the fastest-growing modality through 2035. The segment includes connected blood pressure cuffs, scales, pulse oximeters, glucose devices, spirometers, wearable sensors, and monitoring kits used under physician, health-system, payer, or home-health oversight. Growth is supported by Medicare reimbursement, Medicare Advantage care management, hospital-at-home programs, and value-based contracting. Vendor differentiation increasingly depends on patient adherence, logistics, integration, and clinical service design rather than hardware cost alone.
Ambulatory wearable monitoring accounted for approximately USD 2.93 billion in 2025. It captures patients during normal daily activity and is especially important in arrhythmia detection, rehabilitation, sleep assessment, post-operative recovery, and episodic symptom evaluation. Ambulatory systems must balance diagnostic depth with comfort and simplicity. Longer wear duration can increase clinical yield, but it also increases the importance of adhesive quality, battery life, patient instructions, and data filtering.
Intermittent and connected spot-check monitoring represented about USD 1.76 billion in 2025. This segment includes smart vital-sign carts, connected thermometers, blood pressure devices, pulse oximeters, and handheld diagnostic tools used during rounds, triage, clinics, and home care. Growth depends on automated documentation, barcode-based patient matching, wireless transmission, and standardized workflows. Conventional devices without connectivity face price pressure, while connected systems can defend value by reducing transcription errors and documentation time.
Implantable continuous monitoring generated approximately USD 1.02 billion in 2025. The category includes implantable loop recorders, hemodynamic sensors, and other long-term devices that transmit data to clinicians. Implantable monitoring serves smaller patient populations than non-invasive systems but generates high value per patient and supports multi-year data capture. Growth will be strongest where evidence shows that earlier detection or treatment adjustment reduces stroke risk, hospitalization, or diagnostic delay.

By Application

Cardiac and vascular monitoring was the largest application segment, valued at an estimated USD 4.10 billion in 2025. It includes arrhythmia detection, heart failure surveillance, blood pressure management, post-procedure observation, implantable device follow-up, and vascular risk monitoring. The segment benefits from a large disease burden and a well-developed specialist ecosystem. Growth is shifting toward longer-duration ambulatory monitoring, connected blood pressure programs, implantable hemodynamic data, and integrated post-discharge pathways.
Diabetes and metabolic monitoring generated approximately USD 3.51 billion in 2025. Continuous glucose monitoring dominates the value pool, supported by recurring sensor consumption and expanding clinical eligibility. Connected weight scales and metabolic monitoring applications add smaller revenue streams. Buyers increasingly evaluate how device data supports medication adjustment, nutrition counseling, automated insulin delivery, and population management. The segment has strong consumer pull, but clinical credibility depends on accuracy, affordability, coverage, and clear interpretation.
Respiratory monitoring accounted for an estimated USD 2.49 billion in 2025. The application includes oxygen saturation, respiratory rate, capnography, sleep-disordered breathing, chronic obstructive pulmonary disease, asthma, and post-acute respiratory surveillance. Hospitals are focused on early detection of opioid-induced respiratory depression and deterioration outside the ICU. Home programs use pulse oximetry, spirometry, and connected positive airway pressure data. Growth will favor systems that combine multiple respiratory signals and reduce false alarms caused by motion or poor perfusion.
Critical care, perioperative, and post-acute monitoring represented approximately USD 2.34 billion in 2025. These applications require reliable continuous data during surgery, recovery, emergency care, intensive care, and the transition home. Smart monitoring is being used to improve handoffs and maintain surveillance when patients move between departments. Wireless transport, automated charting, and integrated alarm management are key purchasing criteria. Post-acute monitoring is expanding because hospitals want earlier detection of complications after discharge.
Neurological, sleep, maternal, pediatric, and other specialty monitoring generated an estimated USD 2.21 billion in 2025. The segment includes EEG-related monitoring, sleep diagnostics, cerebral oxygenation, maternal-fetal surveillance, neonatal monitoring, temperature and seizure-related devices, and other specialized applications. These markets are smaller individually but can grow quickly when a device improves access or reduces the need for facility-based testing. Pediatric and neonatal adoption requires particularly strong accuracy, comfort, and alarm-performance evidence.

By End User

Hospitals and integrated health systems were the dominant end users, accounting for approximately USD 6.15 billion in 2025. They purchase bedside monitors, telemetry, wearable surveillance, transport systems, central monitoring infrastructure, software, sensors, and enterprise service agreements. Large health systems increasingly standardize vendors across facilities to reduce training, simplify integration, and improve purchasing leverage. Their value analysis committees consider capital cost, consumables, alarm performance, cybersecurity, uptime, service coverage, and the effect on nursing workflow.
Home healthcare, virtual care, and remote patient monitoring providers generated an estimated USD 3.37 billion in 2025. This group includes health-system virtual wards, physician-led RPM programs, home health agencies, digital care companies, and payer-sponsored monitoring programs. Growth is rapid, but business models vary widely. Sustainable programs typically focus on defined clinical populations, reliable patient onboarding, high transmission rates, and clear escalation protocols. Device vendors that can support logistics and documentation have an advantage over hardware-only suppliers.
Ambulatory clinics, specialty practices, and ambulatory surgery centers accounted for approximately USD 2.05 billion in 2025. Cardiology, endocrinology, pulmonology, primary care, sleep medicine, and post-operative practices use connected devices to extend observation beyond the visit. These buyers prioritize ease of deployment, reimbursement support, low operational burden, and integration with practice systems. They are more price-sensitive than large hospitals but can adopt rapidly when a program produces recurring clinical revenue or reduces avoidable visits.
Skilled nursing facilities, rehabilitation centers, and long-term care providers represented about USD 1.61 billion in 2025. Residents often have multiple chronic conditions and high risk of deterioration, yet facilities may lack on-site specialists. Connected monitoring can support earlier escalation and reduce unnecessary transfers when used with telemedicine and clinician oversight. Adoption is constrained by staffing, broadband reliability, fragmented records, and reimbursement complexity. Devices that are simple, durable, and centrally managed are best positioned.
Diagnostic centers, emergency medical services, and telehealth networks generated approximately USD 1.47 billion in 2025. This segment includes ambulatory diagnostic monitoring, mobile assessment, community screening, and connected devices used during virtual consultations. Growth is supported by decentralized testing and the need to capture objective data outside hospitals. Buyers favor compact devices, rapid setup, cloud connectivity, and reports that can be reviewed across locations.

Regional Insights: Where the Market is Growing Fastest

The U.S. Smart Patient Monitoring Devices Market is geographically segmented into the South, West, Northeast, and Midwest using a four-region framework. Regional performance is shaped by population scale, chronic disease burden, older-adult concentration, hospital-system density, digital health investment, Medicare Advantage penetration, rural access needs, state telehealth policy, and the presence of academic medical centers. The South was the largest regional market in 2025, while the West is expected to record the fastest growth through 2035. The Northeast has the highest concentration of premium academic and enterprise monitoring deployments, and the Midwest offers a stable base of hospital, cardiac, diabetes, and rural monitoring demand.

South

The South accounted for an estimated USD 5.13 billion in 2025, representing about 35% of the national market. The region includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, the District of Columbia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas. Its leadership is supported by population growth, high prevalence of hypertension and diabetes, large Medicare populations, extensive hospital networks, and significant rural access gaps. The region is expected to reach approximately USD 16.80 billion by 2035, broadly maintaining its national share.

Texas is the largest state market in the South and generated an estimated USD 1.22 billion in 2025. Houston, Dallas-Fort Worth, Austin, and San Antonio support major integrated health systems, academic centers, specialty practices, and technology-oriented care models. Texas offers strong demand for hospital telemetry, connected cardiology, diabetes monitoring, post-acute surveillance, and rural monitoring. The state’s scale creates opportunity, but procurement is concentrated among large systems that expect enterprise pricing, integration, and service support.

Florida represented an estimated USD 0.86 billion in 2025 and is one of the most strategically important monitoring markets because of its large older-adult population. Demand is strong for cardiac rhythm monitoring, connected blood pressure management, continuous glucose monitoring, respiratory surveillance, and home-based care. Miami, Tampa, Orlando, Jacksonville, and South Florida retirement communities provide diverse channels. Medicare Advantage and home-health activity create favorable conditions, although vendor competition is intense.

North Carolina, Georgia, Tennessee, Virginia, and Maryland are high-opportunity state markets. North Carolina benefits from large academic systems, life-science infrastructure, and expanding population centers. Georgia combines Atlanta-based health-system demand with rural access needs. Tennessee has major hospital operators and strong specialty care networks. Virginia and Maryland benefit from affluent metropolitan markets, federal healthcare influence, and sophisticated provider systems. These states are attractive for enterprise monitoring, virtual nursing, hospital-at-home, and chronic disease programs.

Alabama, Mississippi, Louisiana, Kentucky, West Virginia, Arkansas, and Oklahoma have elevated chronic disease burdens and substantial need for hypertension, diabetes, cardiac, and respiratory monitoring. Their opportunity is not limited to low-cost devices. Regional referral centers can adopt premium hospital systems, while rural communities require scalable home-based monitoring linked to telehealth and local clinicians. South Carolina and Delaware provide smaller but growing markets, and the District of Columbia is important because of its concentration of advanced hospitals and public health institutions.

The South’s principal strategic challenge is uneven care capacity. Large metropolitan systems can implement sophisticated command centers and integrated monitoring platforms, while rural hospitals and clinics may struggle with staffing, connectivity, and implementation resources. Vendors that offer modular deployment, cellular connectivity, managed services, and regional clinical support can address both ends of the market. The region will remain the largest source of incremental unit demand through 2035.

West

The West represented an estimated USD 3.37 billion in 2025 and is expected to grow at an above-market CAGR of approximately 14.0%, reaching about USD 12.50 billion by 2035. The region includes Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, Wyoming, Alaska, California, Hawaii, Oregon, and Washington. Growth is supported by digital health adoption, technology investment, population expansion in the Mountain West, large integrated delivery networks, and strong interest in care outside the hospital.

California was the largest state market in the West, valued at an estimated USD 1.56 billion in 2025. The state combines a large population, advanced academic centers, health-system innovation programs, medtech companies, software developers, and venture-backed digital health firms. California is a leading adoption market for wearable biosensors, AI-assisted monitoring, connected diabetes care, virtual wards, and ambulatory cardiac systems. Procurement can be demanding because buyers expect interoperability, evidence, cybersecurity, and enterprise scalability.

Arizona and Nevada are fast-growing markets because of population growth and aging demographics. Arizona generated an estimated USD 0.29 billion in 2025 and has strong demand for cardiac, diabetes, respiratory, and home-based monitoring. Nevada’s concentrated metropolitan population supports scalable hospital and outpatient deployments. Colorado and Utah are also attractive because of integrated delivery networks, digitally engaged populations, and health-system experimentation with virtual care and remote surveillance.

Washington and Oregon have strong health-system adoption of connected care, population health, and enterprise monitoring. Seattle’s technology ecosystem supports partnerships between providers and digital health companies, while Oregon has a strong need for monitoring across urban and geographically dispersed communities. New Mexico, Idaho, Montana, Wyoming, and Alaska are smaller markets but have high strategic relevance for cellular-enabled devices, rural telehealth, and home monitoring where travel distance limits frequent in-person care.

Hawaii presents a distinctive opportunity because inter-island geography increases the value of remote monitoring and specialist access. The West’s overall growth will be driven by technology-forward health systems and the migration of care into ambulatory and home settings. However, vendors must manage state-level privacy expectations, health-system integration requirements, and the need to support both dense urban markets and remote rural populations.

Northeast

The Northeast accounted for an estimated USD 3.22 billion in 2025 and is expected to reach approximately USD 9.90 billion by 2035. The region includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, and Pennsylvania. It has the highest concentration of academic medical centers, specialist networks, research institutions, and evidence-driven value analysis. Growth is slightly slower than the West because the market is mature, but average selling prices and deployment complexity are often higher.

New York was the largest state market in the Northeast, valued at an estimated USD 0.79 billion in 2025. New York City and major upstate systems support large-scale telemetry, cardiac monitoring, diabetes programs, remote care, and hospital-at-home initiatives. Procurement is influenced by unionized labor environments, dense hospital networks, and the need to manage large, diverse patient populations. Systems that reduce manual documentation and improve centralized visibility are strategically attractive.

Pennsylvania represented an estimated USD 0.50 billion in 2025, supported by large academic systems, community networks, and an aging population. Massachusetts generated approximately USD 0.34 billion despite its smaller population because of its research intensity, teaching hospitals, and early adoption of advanced monitoring technologies. New Jersey and Connecticut are important suburban and metropolitan markets with strong specialist density and commercial insurance coverage.

Maine, New Hampshire, Vermont, and Rhode Island are smaller state markets but create targeted opportunity for remote monitoring, rural access, and aging-population management. The region’s provider systems often require detailed clinical evidence, implementation governance, and cybersecurity review before adoption. Once a platform is approved, however, enterprise rollouts can create durable revenue through service contracts, sensors, and replacement cycles.

The Northeast is particularly influential in validating new monitoring models. Academic institutions can generate clinical evidence, develop alert protocols, and shape national practice patterns. Manufacturers often use the region for early deployment of AI-assisted surveillance, specialty monitoring, and complex virtual-care programs. The region will remain one of the most profitable markets even if its unit growth trails the South and West.

Midwest

The Midwest represented an estimated USD 2.93 billion in 2025 and is projected to reach approximately USD 8.80 billion by 2035. The region includes Indiana, Illinois, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota. Demand is supported by established hospital networks, high chronic disease prevalence in several states, strong cardiac and diabetes care infrastructure, and large rural service territories.

Illinois generated an estimated USD 0.44 billion in 2025, led by the Chicago metropolitan area and major academic and community systems. Ohio represented approximately USD 0.38 billion and has strong demand across cardiac, respiratory, diabetes, and inpatient monitoring. Michigan accounted for about USD 0.28 billion, supported by large health systems and a significant chronic disease burden. These states offer scale for enterprise contracts and replacement of legacy monitoring infrastructure.

Minnesota is strategically important because of its medical device ecosystem, integrated providers, and history of patient-monitoring innovation. Wisconsin, Indiana, and Missouri provide stable hospital and outpatient demand, with growing interest in connected chronic disease programs. Iowa, Kansas, and Nebraska are important for regional referral models and rural monitoring, while North Dakota and South Dakota offer smaller but relevant opportunities for cellular-connected devices and telehealth-enabled care.

The Midwest tends to place strong emphasis on reliability, service responsiveness, and economic value. Health systems may adopt more deliberately than coastal academic centers, but successful deployments can scale across broad regional networks. Vendors that provide clinical education, biomedical engineering support, and clear cost-per-patient economics are well positioned. The region will remain a dependable market for both mature bedside systems and emerging home-monitoring programs.

Key Market Players

The U.S. Smart Patient Monitoring Devices Competitive Landscape is moderately consolidated in enterprise hospital monitoring, continuous glucose monitoring, and large-scale cardiac diagnostics, while remaining fragmented in wearable biosensors, specialty monitoring, remote care platforms, and connected peripherals. Large medtech companies compete through installed base, regulatory expertise, hospital contracting, integration, and national service organizations. Specialized companies compete through sensor innovation, focused algorithms, faster implementation, and narrower clinical use cases.

Competition is increasingly ecosystem-based. Hospital buyers prefer platforms that can connect bedside monitors, telemetry, transport devices, wearable sensors, central stations, and mobile alerts. Remote-care buyers evaluate device logistics, patient engagement, data review, reimbursement documentation, and integration. Market share through 2035 will be influenced by evidence quality, cybersecurity maturity, interoperability, consumable economics, and the ability to demonstrate a measurable impact on clinician workload and patient outcomes.

Some of the key players in the U.S. Smart Patient Monitoring Devices industry are

Koninklijke Philips N.V.,
GE HealthCare Technologies Inc.,
Medtronic plc,
Abbott Laboratories,
Masimo Corporation,
Baxter International Inc.,
DexCom, Inc.,
Boston Scientific Corporation,
iRhythm Technologies, Inc.,
Nihon Kohden Corporation,
Drägerwerk AG & Co. KGaA,
Siemens Healthineers AG,
Edwards Lifesciences Corporation,
ResMed Inc.,
OMRON Healthcare, Inc.,
ZOLL Medical Corporation,
BioIntelliSense, Inc.,
VitalConnect, Inc.,
Sibel Health, Inc.,
AliveCor, Inc.,
Nonin Medical, Inc.,
Spacelabs Healthcare,
A&D Medical,
Current Health.

Philips, GE HealthCare, Baxter, Nihon Kohden, Dräger, Masimo, and Spacelabs are prominent in hospital and enterprise patient monitoring. Abbott, Dexcom, and Medtronic have strong positions in continuous glucose monitoring and connected diabetes ecosystems. Boston Scientific, iRhythm, Philips, AliveCor, and ZOLL are important in ambulatory and remote cardiac monitoring. BioIntelliSense, VitalConnect, Sibel Health, Current Health, Nonin, OMRON, and A&D Medical compete across wearable sensors, remote monitoring, connected blood pressure, pulse oximetry, and home-based care.

The market will reward companies that can combine hardware, software, clinical services, and implementation discipline. Large suppliers have advantages in contracting and service coverage, but smaller innovators can gain share when they solve a specific problem such as continuous ward surveillance, high-adherence cardiac monitoring, neonatal wearability, or simplified home deployment. Acquisitions and strategic partnerships are likely as larger companies seek differentiated sensors, algorithms, and remote-care capabilities.

Recent Developments

Recent developments in the U.S. Smart Patient Monitoring Devices Market show a rapid expansion of sensor-based care across hospitals and homes. In 2024, the FDA cleared the first over-the-counter continuous glucose monitor, creating a new consumer-access pathway for glucose trend data. Abbott also received clearance for Libre Rio, an over-the-counter integrated continuous glucose monitor for non-intensive glucose management. These developments broadened awareness of continuous monitoring and intensified competition around sensor wear time, usability, pricing, and app-based interpretation.

In April 2025, the FDA cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System, extending sensor duration for adults. Longer-wear CGM can improve convenience and reduce replacement frequency, but it also raises expectations for adhesive performance, accuracy over the full wear period, and reliable digital connectivity. In 2026, additional sensor-based digital health device clearances continued, demonstrating that the regulatory pipeline remains active across glucose, cardiac, sleep, and other monitoring categories.

Hospital monitoring platforms also advanced. GE HealthCare expanded the Portrait ecosystem after receiving clearance for wireless wearable continuous monitoring and later for a connected vital-sign workflow that imports patient information and continuous respiratory rate, oxygen saturation, and pulse data. These developments illustrate the industry’s movement toward uninterrupted monitoring, automated documentation, and fewer manual steps during clinical rounds.

Philips launched a next-generation smart telemetry platform in 2025 designed to support enterprise-wide cardiac monitoring beyond the bedside. The platform emphasized patient mobility, scalable capacity, and tools intended to filter non-actionable alarms. In 2026, a large Texas health system selected a broad Philips enterprise monitoring platform spanning intensive care, operating rooms, procedural areas, transport, and wearable telemetry. Such contracts show that U.S. hospitals are standardizing monitoring at the system level rather than purchasing isolated units.

Masimo expanded connected monitoring through FDA clearances for medical wearables and over-the-counter pulse oximetry. Its 2024 clearance for the W1 Medical Watch to connect with the SafetyNet telemonitoring system demonstrated the convergence of wearable form factors and clinician-facing remote monitoring. The company also received clearance for an over-the-counter fingertip pulse oximeter, illustrating continued movement of selected medical measurements into consumer-access channels.

Regulatory and reimbursement policy is becoming more demanding. Medicare remote patient monitoring use continued to grow in 2024, but federal oversight highlighted billing patterns and incomplete delivery of service components. CMS also refined remote-monitoring rate-setting and continued to support remote physiologic monitoring as part of the physician fee schedule. These changes favor vendors that help providers document compliant, clinically meaningful monitoring rather than simply maximize device enrollment.

AI-enabled device regulation is also advancing. FDA lifecycle guidance and predetermined change control plan frameworks are increasing expectations for ongoing performance monitoring, transparency, and post-market management. For patient monitoring manufacturers, this means that predictive algorithms must be supported by strong data governance and quality systems. The commercial opportunity remains significant, but buyers will increasingly ask how an algorithm performs across age, sex, race, skin tone, comorbidity, motion, and care-setting differences.

The competitive landscape is likely to consolidate further. Enterprise monitoring companies are partnering with sensor developers, while remote-care platforms are seeking broader device libraries and deeper EHR integration. Continuous glucose and cardiac monitoring companies are expanding data services, and hospital suppliers are adding wireless and wearable products. Through 2035, successful portfolios will connect acute, ambulatory, and home monitoring while preserving clinical accountability.

Conclusion

The U.S. Smart Patient Monitoring Devices Market Size & Share is positioned to expand from USD 14.65 billion in 2025 to USD 48.00 billion by 2035, supported by a 12.60% CAGR during the forecast period. The market’s long-term strength is grounded in chronic disease burden, population aging, connected-device familiarity, reimbursement-enabled remote care, near-universal EHR adoption, and hospital demand for earlier deterioration detection and more efficient clinical workflows.

The most attractive growth opportunities will come from wearable biosensors, continuous glucose monitoring, ambulatory cardiac monitoring, connected blood pressure management, wireless hospital surveillance, smart respiratory monitoring, hospital-at-home devices, and AI-assisted alarm prioritization. Conventional bedside and spot-check systems will remain important, but value growth will increasingly depend on interoperability, mobility, automated documentation, and the ability to support care beyond the hospital.

Regional opportunity will be led by the South because of population scale, chronic disease burden, Medicare demand, and expanding health systems. The West will record the fastest growth because of technology adoption, digital health investment, and population expansion. The Northeast will remain the most evidence-intensive and premium market, while the Midwest will provide stable demand across hospitals, cardiac care, diabetes management, and rural monitoring. California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, North Carolina, Massachusetts, Georgia, Arizona, and Michigan will be particularly important state markets.

For clients evaluating this market, the central question is not whether connected monitoring will expand. The key questions are which clinical pathways can sustain high patient adherence, where monitoring data will trigger timely action, how procurement will balance device cost against labor and utilization savings, and which vendors can meet increasingly strict integration and cybersecurity requirements. Companies that combine validated sensors, efficient workflows, disciplined service delivery, and credible outcomes evidence will define the next decade of the U.S. smart patient monitoring devices industry.

TABLE OF CONTENT

1. U.S. Smart Patient Monitoring Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.2.1. Devices and Solutions Included in the Market Scope
1.2.2. Clinical-Grade Smart Monitoring Devices Included
1.2.3. Consumer Wellness Devices Excluded from the Market Scope
1.2.4. Geographic, Historical, Base Year, and Forecast Boundaries
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Bottom-Up and Top-Down Market Sizing
1.3.6. Device Installed-Base and Recurring Sensor Revenue Modeling
1.3.7. Analytical Frameworks & Forecasting Models
1.3.8. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Smart Patient Monitoring Device Manufacturers
1.6.2. Sensor, Semiconductor, Connectivity, and Component Suppliers
1.6.3. Contract Manufacturers and Device Logistics Providers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Ambulatory Clinics, Specialty Practices, and Surgery Centers
1.6.6. Home Healthcare, Virtual Care, and Remote Monitoring Providers
1.6.7. Group Purchasing Organizations, Distributors, and Pharmacy Channels
1.6.8. Payers, Regulators, Health IT Teams, and Clinical Decision-Makers
What this section provides: This section defines the market boundary, included device classes, study scope, methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. smart patient monitoring devices market is measured, segmented, and validated.

2. U.S. Smart Patient Monitoring Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Revenue Opportunity by Device, Monitoring Modality, and Care Setting
2.8. High-Growth Opportunity Areas
2.9. Key Strategic Findings for Manufacturers, Providers, and Investors
What this section provides: This section gives decision-makers a concise view of market size, growth direction, leading device categories, care-setting demand, competitive intensity, and the most attractive smart monitoring opportunities through 2035.

3. U.S. Smart Patient Monitoring Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Chronic Disease and Multimorbidity Burden
3.1.2. Rapid Growth of the U.S. Older-Adult Population
3.1.3. Expansion of Remote Physiologic Monitoring and Virtual Care
3.1.4. Extension of Continuous Monitoring Beyond Intensive Care Units
3.1.5. Hospital Workforce Pressure and Virtual Nursing Adoption
3.1.6. Growth of Continuous Glucose and Ambulatory Cardiac Monitoring
3.1.7. Increasing EHR Interoperability and Connected Care Infrastructure
3.2. Restraints and Their Impact Analysis
3.2.1. High Device, Integration, and Implementation Costs
3.2.2. Alarm Fatigue, Data Overload, and Clinician Workflow Burden
3.2.3. Reimbursement Variability and Documentation Requirements
3.2.4. Patient Adherence, Digital Literacy, and Access Barriers
3.2.5. Cybersecurity, Privacy, and Interoperability Constraints
3.2.6. Sensor Accuracy, Artifact, and Clinical Validation Challenges
3.3. Opportunities and Their Impact Analysis
3.3.1. Wearable Biosensor and Smart Patch Adoption
3.3.2. AI-Assisted Deterioration Detection and Alarm Prioritization
3.3.3. Hospital-at-Home and Virtual Ward Monitoring
3.3.4. Connected Hypertension, Diabetes, and Heart Failure Programs
3.3.5. Rural and Medically Underserved Population Monitoring
3.3.6. Enterprise Monitoring Platforms Across Acute and Home Care
3.3.7. Longer-Wear Sensors and Recurring Consumable Revenue Models
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Remote Monitoring Reimbursement Economics Analysis
3.9. Patient Engagement and Device Adherence Analysis
What this section provides: This section explains the clinical, commercial, reimbursement, operational, and technology forces shaping demand, enabling clients to assess market upside, adoption barriers, and execution risk.

4. U.S. Smart Patient Monitoring Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Connected Monitoring Data Flow and Interoperability Architecture
4.6. Impact of Digitalization, AI, and Predictive Analytics
4.7. Application & Innovation Landscape
4.8. FDA Regulatory Framework Analysis
4.9. CMS Reimbursement and Coverage Landscape
4.10. Connected Device Cybersecurity and Data Privacy Landscape
4.11. Import/Export Restrictions & Tariff Impact
4.12. Government Initiatives, Hospital-at-Home, and Public Health Programs
4.13. Impact of Escalating Geopolitical Tensions
4.14. Hospital Value Analysis Committee Decision Framework
4.15. EHR Integration, Alarm Governance, and Clinical Adoption Framework
What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, pricing, supply chain, interoperability, cybersecurity, AI adoption, and healthcare procurement dynamics.

5. U.S. Smart Patient Monitoring Devices Market: By Device Type

5.1. Overview
5.1.1. Segment Share Analysis, By Device Type, 2025 & 2035 (%)
5.1.2. Wearable Biosensors and Smart Patches
5.1.2.1. ECG and Cardiac Rhythm Patches
5.1.2.2. Multiparameter Vital-Sign Wearables
5.1.2.3. Temperature, Activity, and Recovery Sensors
5.1.2.4. Medical-Grade Smart Watches and Wrist-Worn Devices
5.1.3. Smart Multiparameter, Bedside, and Transport Monitors
5.1.3.1. High-Acuity Bedside Monitors
5.1.3.2. Wireless Medical-Surgical Floor Monitors
5.1.3.3. Transport and Mobile Patient Monitors
5.1.3.4. Central Monitoring Stations and Telemetry Systems
5.1.4. Smart Glucose Monitoring Systems
5.1.4.1. Prescription Continuous Glucose Monitors
5.1.4.2. Over-the-Counter Continuous Glucose Monitors
5.1.4.3. Connected Blood Glucose Meters
5.1.4.4. Integrated CGM and Automated Insulin Delivery Interfaces
5.1.5. Connected Cardiac Monitoring Devices
5.1.5.1. Mobile Cardiac Telemetry Systems
5.1.5.2. Holter and Event Monitoring Devices
5.1.5.3. Handheld and Consumer-Accessible Medical ECG Devices
5.1.5.4. Implantable Loop Recorders and Connected Cardiac Sensors
5.1.6. Smart Respiratory and Specialty Monitoring Devices
5.1.6.1. Connected Pulse Oximeters and Capnography Devices
5.1.6.2. Smart Spirometers and Sleep Monitoring Systems
5.1.6.3. Neurological and Cerebral Monitoring Devices
5.1.6.4. Maternal, Fetal, Neonatal, and Pediatric Monitoring Devices
5.1.6.5. Connected Weight, Fluid Status, and Other Specialty Devices
What this section provides: This section identifies which smart patient monitoring device categories and subcategories are expected to generate the highest revenue contribution, recurring sensor demand, and growth through 2035.

6. U.S. Smart Patient Monitoring Devices Market: By Monitoring Modality

6.1. Overview
6.1.1. Segment Share Analysis, By Monitoring Modality, 2025 & 2035 (%)
6.1.2. Continuous Non-Invasive Monitoring
6.1.2.1. Single-Parameter Continuous Monitoring
6.1.2.2. Multiparameter Continuous Monitoring
6.1.2.3. Wireless Ward-Based Continuous Surveillance
6.1.3. Remote Home-Based Monitoring
6.1.3.1. Chronic Disease Remote Physiologic Monitoring
6.1.3.2. Post-Discharge and Hospital-at-Home Monitoring
6.1.3.3. Patient-Reported and Device-Generated Hybrid Monitoring
6.1.4. Ambulatory Wearable Monitoring
6.1.4.1. Short-Duration Ambulatory Monitoring
6.1.4.2. Extended-Wear Ambulatory Monitoring
6.1.4.3. Real-Time Mobile Telemetry Monitoring
6.1.5. Intermittent and Connected Spot-Check Monitoring
6.1.5.1. Facility-Based Connected Spot Checks
6.1.5.2. Home and Community-Based Spot Checks
6.1.5.3. Automated Documentation and EHR-Linked Measurement
6.1.6. Implantable Continuous Monitoring
6.1.6.1. Implantable Cardiac Rhythm Monitoring
6.1.6.2. Implantable Hemodynamic and Physiologic Monitoring
What this section provides: This section evaluates how frequently, where, and through which monitoring model patient data is collected, helping clients compare continuous, ambulatory, home-based, spot-check, and implantable demand.

7. U.S. Smart Patient Monitoring Devices Market: By Application

7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
7.1.2. Cardiac and Vascular Monitoring
7.1.2.1. Arrhythmia Detection and Rhythm Surveillance
7.1.2.2. Hypertension and Blood Pressure Management
7.1.2.3. Heart Failure and Fluid Status Monitoring
7.1.2.4. Post-Procedure and Stroke-Risk Monitoring
7.1.3. Diabetes and Metabolic Monitoring
7.1.3.1. Continuous Glucose Monitoring
7.1.3.2. Connected Blood Glucose Monitoring
7.1.3.3. Weight, Activity, and Metabolic Trend Monitoring
7.1.4. Respiratory Monitoring
7.1.4.1. Oxygen Saturation and Respiratory Rate Monitoring
7.1.4.2. Capnography and Opioid Safety Monitoring
7.1.4.3. COPD, Asthma, and Home Respiratory Monitoring
7.1.4.4. Sleep-Disordered Breathing Monitoring
7.1.5. Critical Care, Perioperative, and Post-Acute Monitoring
7.1.5.1. Intensive and Emergency Care Monitoring
7.1.5.2. Operating Room and Procedural Monitoring
7.1.5.3. Medical-Surgical Floor Deterioration Surveillance
7.1.5.4. Post-Discharge and Rehabilitation Monitoring
7.1.6. Neurological, Sleep, Maternal, Pediatric, and Other Specialty Monitoring
7.1.6.1. Neurological and Seizure-Related Monitoring
7.1.6.2. Maternal and Fetal Monitoring
7.1.6.3. Neonatal and Pediatric Monitoring
7.1.6.4. Sleep, Temperature, and Other Specialty Applications
What this section provides: This section helps clients understand demand by clinical use case and prioritize applications with strong disease burden, recurring monitoring need, reimbursement relevance, and device innovation.

8. U.S. Smart Patient Monitoring Devices Market: By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Hospitals and Integrated Health Systems
8.1.2.1. Intensive Care, Emergency, and Operating Room Departments
8.1.2.2. Medical-Surgical Floors and Central Monitoring Units
8.1.2.3. Hospital-at-Home and Virtual Command Centers
8.1.3. Home Healthcare, Virtual Care, and Remote Monitoring Providers
8.1.3.1. Health System-Led Remote Monitoring Programs
8.1.3.2. Physician-Led Remote Physiologic Monitoring Programs
8.1.3.3. Home Health and Digital Care Management Providers
8.1.4. Ambulatory Clinics, Specialty Practices, and Surgery Centers
8.1.4.1. Cardiology and Electrophysiology Practices
8.1.4.2. Endocrinology, Primary Care, and Metabolic Clinics
8.1.4.3. Pulmonology, Sleep, and Other Specialty Practices
8.1.4.4. Ambulatory Surgery Centers and Procedure Clinics
8.1.5. Skilled Nursing, Rehabilitation, and Long-Term Care Facilities
8.1.5.1. Skilled Nursing Facilities
8.1.5.2. Inpatient and Outpatient Rehabilitation Centers
8.1.5.3. Assisted Living and Long-Term Care Providers
8.1.6. Diagnostic Centers, Emergency Medical Services, and Telehealth Networks
8.1.6.1. Independent Diagnostic and Ambulatory Monitoring Centers
8.1.6.2. Emergency Medical Services and Mobile Care Providers
8.1.6.3. Telehealth and Community-Based Monitoring Networks
What this section provides: This section explains which care settings and customer groups are expected to drive equipment purchasing, recurring sensor utilization, connected monitoring adoption, and service revenue.

9. U.S. Smart Patient Monitoring Devices Market: By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Capital Equipment Purchases
9.1.2.2. Sensor, Accessory, and Consumable Contracts
9.1.2.3. Software, Service, and Integration Agreements
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Multi-Facility Vendor Standardization
9.1.3.2. Enterprise Telemetry and Monitoring Platform Agreements
9.1.3.3. Outcome-Based and Managed Service Contracts
9.1.4. Group Purchasing Organization and Distributor Channels
9.1.4.1. National and Regional GPO Contracts
9.1.4.2. Medical Device Distributor Sales
9.1.4.3. Specialty Supplier and Logistics Partnerships
9.1.5. Ambulatory, Physician Group, and Specialty Practice Procurement
9.1.5.1. Direct Practice Purchasing
9.1.5.2. Diagnostic Service and Monitoring Center Contracts
9.1.5.3. Leasing and Subscription-Based Procurement
9.1.6. Remote Monitoring Platform and Care Management Contracts
9.1.6.1. Device-Enabled Service Agreements
9.1.6.2. Per-Patient-Per-Month Monitoring Contracts
9.1.6.3. Payer, Employer, and Value-Based Care Contracts
9.1.7. Pharmacy, Retail, and Consumer-Accessible Medical Device Channels
What this section provides: This section explains how smart patient monitoring devices are purchased and deployed in the U.S., including hospital capital buying, IDN standardization, GPO influence, subscriptions, managed services, and consumer-access channels.

10. U.S. Smart Patient Monitoring Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Chronic Disease Burden and Addressable Patient Population
10.1.4. Regional Hospital, Ambulatory, and Home-Care Infrastructure Analysis
10.1.5. Regional Reimbursement, Digital Health, and Procurement Dynamics
10.1.6. Regional Connectivity, Rural Access, and Monitoring Adoption Analysis
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Smart Patient Monitoring Device Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Smart Patient Monitoring Device Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Smart Patient Monitoring Device Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.24. Delaware
10.4.24.1. Overview
10.4.24.2. Delaware Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.24.3. Delaware Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.24.4. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.24.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.24.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.25. District of Columbia
10.4.25.1. Overview
10.4.25.2. District of Columbia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.25.3. District of Columbia Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.4.25.4. District of Columbia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.25.5. District of Columbia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.25.6. District of Columbia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Smart Patient Monitoring Device Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Monitoring Modality, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. geographies, health-system clusters, chronic disease demand centers, virtual-care adoption hotspots, and state-level commercial opportunities.

11. U.S. Smart Patient Monitoring Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Koninklijke Philips N.V.
11.3.2. GE HealthCare Technologies Inc.
11.3.3. Medtronic plc
11.3.4. Abbott Laboratories
11.3.5. Masimo Corporation
11.3.6. Baxter International Inc.
11.3.7. DexCom, Inc.
11.3.8. Boston Scientific Corporation
11.3.9. iRhythm Technologies, Inc.
11.3.10. Nihon Kohden Corporation
11.3.11. Drägerwerk AG & Co. KGaA
11.3.12. Siemens Healthineers AG
11.3.13. Edwards Lifesciences Corporation
11.3.14. ResMed Inc.
11.3.15. OMRON Healthcare, Inc.
11.3.16. ZOLL Medical Corporation
11.3.17. BioIntelliSense, Inc.
11.3.18. VitalConnect, Inc.
11.3.19. Sibel Health, Inc.
11.3.20. AliveCor, Inc.
11.3.21. Nonin Medical, Inc.
11.3.22. Spacelabs Healthcare
11.3.23. A&D Medical
11.3.24. Current Health
11.4. Competitive Benchmarking by Device Portfolio and Care Setting
11.5. Product Launch, Partnership, Acquisition, and Regulatory Strategy Analysis
11.6. Hospital Enterprise Contracting and Installed-Base Positioning
11.7. Innovation Pipeline and Emerging Competitor Watchlist
Note: Each company profile will include company overview, smart patient monitoring portfolio, U.S. market strategy, financial positioning, installed base, clinical evidence, regulatory updates, interoperability capabilities, partnerships, and recent developments.
What this section provides: This section gives clients competitor benchmarking, market share visibility, portfolio positioning, innovation direction, enterprise contracting intelligence, and strategic profiles of major smart monitoring companies.

12. U.S. Smart Patient Monitoring Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. AI-Assisted Deterioration Detection and Predictive Monitoring
12.2.2. Next-Generation Wearable Biosensors and Smart Patches
12.2.3. Continuous Glucose and Multimodal Metabolic Monitoring
12.2.4. Hospital-at-Home, Virtual Wards, and Command Centers
12.2.5. Ambient, Contactless, and Camera-Based Monitoring
12.2.6. Implantable and Long-Duration Physiologic Sensors
12.2.7. Edge Computing, 5G, and Real-Time Connected Monitoring
12.3. Emerging Business Trends
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Reimbursement and Regulatory Evolution Outlook
12.7. Enterprise Platform Consolidation Outlook
What this section provides: This section prepares clients for future technology shifts, reimbursement changes, care-delivery transformation, market consolidation, investment opportunities, and adoption scenarios through 2035.

13. U.S. Smart Patient Monitoring Devices Market: Strategic Recommendations

13.1. Recommendations for Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Virtual Care and Remote Monitoring Providers
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors, GPOs, and Channel Partners
13.6. Recommendations for New Entrants and Startups
13.7. Go-to-Market Strategy Considerations
13.8. Product Positioning and Portfolio Expansion Guidance
13.9. Clinical Evidence and Health Economic Evidence Priorities
13.10. Interoperability, Cybersecurity, and Implementation Strategy
13.11. State and Regional Commercial Prioritization
What this section provides: This section converts market intelligence into actionable strategy for product development, clinical evidence, market access, enterprise selling, channel expansion, investment decisions, and competitive differentiation.

14. U.S. Smart Patient Monitoring Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Sizing and Forecasting Limitation
14.4. Regulatory and Reimbursement Information Limitation
14.5. Legal Disclaimer
14.6. Third-Party Data Disclaimer
What this section provides: This section clarifies the report’s scope, methodology boundaries, data-use terms, legal limitations, regulatory context, and forecasting assumptions.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Smart Patient Monitoring Devices Market: Market Definition and Scope
TABLE 3: U.S. Smart Patient Monitoring Devices Market: Included Device Classes and Exclusion Criteria
TABLE 4: U.S. Smart Patient Monitoring Devices Market: Research Methodology Framework
TABLE 5: U.S. Smart Patient Monitoring Devices Market: Key Assumptions
TABLE 6: U.S. Smart Patient Monitoring Devices Market: Market Ecosystem and Stakeholder Analysis
TABLE 7: U.S. Smart Patient Monitoring Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Smart Patient Monitoring Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Smart Patient Monitoring Devices Market: Market Attractiveness Index
TABLE 10: U.S. Smart Patient Monitoring Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Smart Patient Monitoring Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Smart Patient Monitoring Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Smart Patient Monitoring Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Smart Patient Monitoring Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Smart Patient Monitoring Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Smart Patient Monitoring Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Smart Patient Monitoring Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Smart Patient Monitoring Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Smart Patient Monitoring Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 20: U.S. Smart Patient Monitoring Devices Market: Remote Monitoring Reimbursement Economics Analysis
TABLE 21: U.S. Smart Patient Monitoring Devices Market: Patient Engagement and Device Adherence Analysis
TABLE 22: U.S. Smart Patient Monitoring Devices Market: Market Risk and Opportunity Assessment Matrix
TABLE 23: U.S. Smart Patient Monitoring Devices Market: PESTEL Analysis
TABLE 24: U.S. Smart Patient Monitoring Devices Market: Porter’s Five Forces Analysis
TABLE 25: U.S. Smart Patient Monitoring Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 26: U.S. Smart Patient Monitoring Devices Market: Value Chain Analysis
TABLE 27: U.S. Smart Patient Monitoring Devices Market: Supply Chain Analysis
TABLE 28: U.S. Smart Patient Monitoring Devices Market: Connected Monitoring Data Flow and Interoperability Architecture
TABLE 29: U.S. Smart Patient Monitoring Devices Market: Digitalization, AI, and Predictive Analytics Impact
TABLE 30: U.S. Smart Patient Monitoring Devices Market: Application & Innovation Landscape
TABLE 31: U.S. Smart Patient Monitoring Devices Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Smart Patient Monitoring Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 33: U.S. Smart Patient Monitoring Devices Market: Connected Device Cybersecurity and Data Privacy Landscape
TABLE 34: U.S. Smart Patient Monitoring Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 35: U.S. Smart Patient Monitoring Devices Market: Government Initiatives, Hospital-at-Home, and Public Health Programs
TABLE 36: U.S. Smart Patient Monitoring Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 37: U.S. Smart Patient Monitoring Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 38: U.S. Smart Patient Monitoring Devices Market: EHR Integration, Alarm Governance, and Clinical Adoption Framework
TABLE 39: U.S. Smart Patient Monitoring Devices Market: External Market Environment Summary
TABLE 40: U.S. Smart Patient Monitoring Devices Market: Device Type Snapshot, 2025
TABLE 41: Segment Dashboard; Definition and Scope, by Device Type
TABLE 42: U.S. Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 43: U.S. Smart Patient Monitoring Devices Market: Segment Share Analysis, by Device Type, 2025 & 2035 (%)
TABLE 44: U.S. Smart Patient Monitoring Devices Market: Wearable Biosensors and Smart Patches Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Smart Patient Monitoring Devices Market: Smart Multiparameter, Bedside, and Transport Monitors Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Smart Patient Monitoring Devices Market: Smart Glucose Monitoring Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Smart Patient Monitoring Devices Market: Connected Cardiac Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Smart Patient Monitoring Devices Market: Smart Respiratory and Specialty Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Smart Patient Monitoring Devices Market: Monitoring Modality Snapshot, 2025
TABLE 50: Segment Dashboard; Definition and Scope, by Monitoring Modality
TABLE 51: U.S. Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 52: U.S. Smart Patient Monitoring Devices Market: Segment Share Analysis, by Monitoring Modality, 2025 & 2035 (%)
TABLE 53: U.S. Smart Patient Monitoring Devices Market: Continuous Non-Invasive Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Smart Patient Monitoring Devices Market: Remote Home-Based Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Smart Patient Monitoring Devices Market: Ambulatory Wearable Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Smart Patient Monitoring Devices Market: Intermittent and Connected Spot-Check Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Smart Patient Monitoring Devices Market: Implantable Continuous Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Smart Patient Monitoring Devices Market: Application Snapshot, 2025
TABLE 59: Segment Dashboard; Definition and Scope, by Application
TABLE 60: U.S. Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 61: U.S. Smart Patient Monitoring Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 62: U.S. Smart Patient Monitoring Devices Market: Cardiac and Vascular Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Smart Patient Monitoring Devices Market: Diabetes and Metabolic Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Smart Patient Monitoring Devices Market: Respiratory Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Smart Patient Monitoring Devices Market: Critical Care, Perioperative, and Post-Acute Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Smart Patient Monitoring Devices Market: Neurological, Sleep, Maternal, Pediatric, and Other Specialty Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Smart Patient Monitoring Devices Market: End User Snapshot, 2025
TABLE 68: Segment Dashboard; Definition and Scope, by End User
TABLE 69: U.S. Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 70: U.S. Smart Patient Monitoring Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 71: U.S. Smart Patient Monitoring Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Smart Patient Monitoring Devices Market: Home Healthcare, Virtual Care, and Remote Monitoring Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Smart Patient Monitoring Devices Market: Ambulatory Clinics, Specialty Practices, and Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Smart Patient Monitoring Devices Market: Skilled Nursing, Rehabilitation, and Long-Term Care Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Smart Patient Monitoring Devices Market: Diagnostic Centers, Emergency Medical Services, and Telehealth Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Smart Patient Monitoring Devices Market: Procurement Channel Snapshot, 2025
TABLE 77: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 78: U.S. Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 79: U.S. Smart Patient Monitoring Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 80: U.S. Smart Patient Monitoring Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Smart Patient Monitoring Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Smart Patient Monitoring Devices Market: Group Purchasing Organization and Distributor Channels Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Smart Patient Monitoring Devices Market: Ambulatory, Physician Group, and Specialty Practice Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Smart Patient Monitoring Devices Market: Remote Monitoring Platform and Care Management Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Smart Patient Monitoring Devices Market: Pharmacy, Retail, and Consumer-Accessible Medical Device Channels Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Smart Patient Monitoring Devices Market: Regional Snapshot, 2025
TABLE 87: Segment Dashboard; Definition and Scope, by Region
TABLE 88: U.S. Smart Patient Monitoring Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 89: U.S. Smart Patient Monitoring Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 90: West Region U.S. Smart Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 91: West Region U.S. Smart Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 92: West Region U.S. Smart Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 98: California Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 99: California Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 100: California Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 101: California Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 102: California Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 103: Washington Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 104: Washington Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 105: Washington Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 106: Washington Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 107: Washington Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 108: Arizona Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 109: Arizona Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 110: Arizona Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 111: Arizona Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 112: Arizona Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 113: Colorado Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 114: Colorado Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 115: Colorado Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 116: Colorado Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 117: Colorado Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 118: Oregon Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 119: Oregon Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 120: Oregon Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 121: Oregon Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 122: Oregon Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 123: Utah Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 124: Utah Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 125: Utah Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 126: Utah Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 127: Utah Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 128: Nevada Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 129: Nevada Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 130: Nevada Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 131: Nevada Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 132: Nevada Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 133: New Mexico Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 134: New Mexico Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 135: New Mexico Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 136: New Mexico Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 137: New Mexico Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 138: Idaho Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 139: Idaho Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 140: Idaho Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 141: Idaho Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 142: Idaho Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 143: Montana Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 144: Montana Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 145: Montana Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 146: Montana Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 147: Montana Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 148: Wyoming Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 149: Wyoming Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 150: Wyoming Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 151: Wyoming Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 152: Wyoming Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 153: Alaska Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 154: Alaska Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 155: Alaska Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 156: Alaska Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 157: Alaska Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 158: Hawaii Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 159: Hawaii Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 160: Hawaii Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 161: Hawaii Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Hawaii Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: Northeast Region U.S. Smart Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 164: Northeast Region U.S. Smart Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 165: Northeast Region U.S. Smart Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 166: Northeast Region U.S. Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 169: Northeast Region U.S. Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 171: New York Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 172: New York Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 173: New York Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 174: New York Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 175: New York Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 176: Massachusetts Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 179: Massachusetts Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 181: New Jersey Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 182: New Jersey Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 183: New Jersey Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 184: New Jersey Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 185: New Jersey Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 186: Pennsylvania Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 189: Pennsylvania Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 191: Connecticut Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 192: Connecticut Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 193: Connecticut Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 194: Connecticut Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 195: Connecticut Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 196: Maine Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 197: Maine Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 198: Maine Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 199: Maine Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 200: Maine Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 201: Vermont Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 202: Vermont Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 203: Vermont Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 204: Vermont Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 205: Vermont Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 206: New Hampshire Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 209: New Hampshire Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 211: Rhode Island Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 214: Rhode Island Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 216: South Region U.S. Smart Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 217: South Region U.S. Smart Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 218: South Region U.S. Smart Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 221: South Region U.S. Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 222: South Region U.S. Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 223: South Region U.S. Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 224: Texas Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 225: Texas Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 226: Texas Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 227: Texas Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 228: Texas Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 229: Florida Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 230: Florida Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 231: Florida Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 232: Florida Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 233: Florida Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 234: Georgia Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 235: Georgia Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 236: Georgia Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 237: Georgia Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 238: Georgia Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 239: North Carolina Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 240: North Carolina Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 241: North Carolina Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 242: North Carolina Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 243: North Carolina Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 244: Tennessee Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 245: Tennessee Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 246: Tennessee Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 247: Tennessee Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 248: Tennessee Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 249: South Carolina Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 251: South Carolina Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 252: South Carolina Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 253: South Carolina Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 254: Alabama Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 255: Alabama Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 256: Alabama Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 257: Alabama Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 258: Alabama Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 259: Mississippi Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 260: Mississippi Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 261: Mississippi Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 262: Mississippi Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 263: Mississippi Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 264: Louisiana Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 265: Louisiana Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 266: Louisiana Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 267: Louisiana Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 268: Louisiana Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 269: Arkansas Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 270: Arkansas Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 271: Arkansas Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 272: Arkansas Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 273: Arkansas Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 274: Kentucky Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 275: Kentucky Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 276: Kentucky Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 277: Kentucky Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 278: Kentucky Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 279: Oklahoma Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 280: Oklahoma Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 281: Oklahoma Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 282: Oklahoma Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 283: Oklahoma Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 284: Virginia Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 285: Virginia Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 286: Virginia Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 287: Virginia Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 288: Virginia Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 289: Maryland Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 290: Maryland Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 291: Maryland Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 292: Maryland Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 293: Maryland Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 296: West Virginia Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 297: West Virginia Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 298: West Virginia Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 299: Delaware Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 300: Delaware Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 301: Delaware Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 302: Delaware Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: Delaware Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 304: District of Columbia Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 305: District of Columbia Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 306: District of Columbia Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 307: District of Columbia Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 308: District of Columbia Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. Smart Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 310: Midwest Region U.S. Smart Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 311: Midwest Region U.S. Smart Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 312: Midwest Region U.S. Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 313: Midwest Region U.S. Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 314: Midwest Region U.S. Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 315: Midwest Region U.S. Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 316: Midwest Region U.S. Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 317: Illinois Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 318: Illinois Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 319: Illinois Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 320: Illinois Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 321: Illinois Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 322: Ohio Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 323: Ohio Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 324: Ohio Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 325: Ohio Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 326: Ohio Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 327: Michigan Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 328: Michigan Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 329: Michigan Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 330: Michigan Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 331: Michigan Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 332: Minnesota Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 333: Minnesota Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 334: Minnesota Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 335: Minnesota Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 336: Minnesota Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 337: Indiana Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 338: Indiana Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 339: Indiana Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 340: Indiana Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 341: Indiana Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 342: Wisconsin Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 343: Wisconsin Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 344: Wisconsin Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 345: Wisconsin Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 346: Wisconsin Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 347: Missouri Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 348: Missouri Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 349: Missouri Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 350: Missouri Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 351: Missouri Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 352: Iowa Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 353: Iowa Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 354: Iowa Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 355: Iowa Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 356: Iowa Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 357: Kansas Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 358: Kansas Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 359: Kansas Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 360: Kansas Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 361: Kansas Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 362: Nebraska Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 363: Nebraska Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 364: Nebraska Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 365: Nebraska Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 366: Nebraska Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 367: North Dakota Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 368: North Dakota Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 369: North Dakota Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 370: North Dakota Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 371: North Dakota Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 372: South Dakota Smart Patient Monitoring Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 373: South Dakota Smart Patient Monitoring Devices Market, by Monitoring Modality, 2021–2035 (US$ Billion)
TABLE 374: South Dakota Smart Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 375: South Dakota Smart Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 376: South Dakota Smart Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 377: U.S. Smart Patient Monitoring Devices Market: Competitive Landscape Snapshot, 2025
TABLE 378: U.S. Smart Patient Monitoring Devices Market: Key Company Market Share Analysis, 2025
TABLE 379: U.S. Smart Patient Monitoring Devices Market: Company Positioning Matrix
TABLE 380: U.S. Smart Patient Monitoring Devices Market: Product Portfolio and Care-Setting Benchmarking of Key Players
TABLE 381: U.S. Smart Patient Monitoring Devices Market: Strategic Developments, Partnerships, M&A, Regulatory Clearances and Product Launches
TABLE 382: Koninklijke Philips N.V.: Company Profile
TABLE 383: GE HealthCare Technologies Inc.: Company Profile
TABLE 384: Medtronic plc: Company Profile
TABLE 385: Abbott Laboratories: Company Profile
TABLE 386: Masimo Corporation: Company Profile
TABLE 387: Baxter International Inc.: Company Profile
TABLE 388: DexCom, Inc.: Company Profile
TABLE 389: Boston Scientific Corporation: Company Profile
TABLE 390: iRhythm Technologies, Inc.: Company Profile
TABLE 391: Nihon Kohden Corporation: Company Profile
TABLE 392: Drägerwerk AG & Co. KGaA: Company Profile
TABLE 393: Siemens Healthineers AG: Company Profile
TABLE 394: Edwards Lifesciences Corporation: Company Profile
TABLE 395: ResMed Inc.: Company Profile
TABLE 396: OMRON Healthcare, Inc.: Company Profile
TABLE 397: ZOLL Medical Corporation: Company Profile
TABLE 398: BioIntelliSense, Inc.: Company Profile
TABLE 399: VitalConnect, Inc.: Company Profile
TABLE 400: Sibel Health, Inc.: Company Profile
TABLE 401: AliveCor, Inc.: Company Profile
TABLE 402: Nonin Medical, Inc.: Company Profile
TABLE 403: Spacelabs Healthcare: Company Profile
TABLE 404: A&D Medical: Company Profile
TABLE 405: Current Health: Company Profile
TABLE 406: U.S. Smart Patient Monitoring Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 407: U.S. Smart Patient Monitoring Devices Market: Disruptive Technologies Impact Matrix
TABLE 408: U.S. Smart Patient Monitoring Devices Market: Emerging Business Trends
TABLE 409: U.S. Smart Patient Monitoring Devices Market: Business Opportunities for Startups and Existing Players
TABLE 410: U.S. Smart Patient Monitoring Devices Market: Investment Prioritization Matrix
TABLE 411: U.S. Smart Patient Monitoring Devices Market: Reimbursement and Regulatory Evolution Outlook
TABLE 412: U.S. Smart Patient Monitoring Devices Market: Enterprise Platform Consolidation Outlook
TABLE 413: U.S. Smart Patient Monitoring Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 414: U.S. Smart Patient Monitoring Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 415: U.S. Smart Patient Monitoring Devices Market: Strategic Recommendations for Virtual Care and Remote Monitoring Providers
TABLE 416: U.S. Smart Patient Monitoring Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 417: U.S. Smart Patient Monitoring Devices Market: Strategic Recommendations for Distributors, GPOs, and Channel Partners
TABLE 418: U.S. Smart Patient Monitoring Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 419: U.S. Smart Patient Monitoring Devices Market: Go-to-Market Strategy Considerations
TABLE 420: U.S. Smart Patient Monitoring Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 421: U.S. Smart Patient Monitoring Devices Market: Clinical Evidence and Health Economic Evidence Priorities
TABLE 422: U.S. Smart Patient Monitoring Devices Market: Interoperability, Cybersecurity, and Implementation Strategy
TABLE 423: U.S. Smart Patient Monitoring Devices Market: State and Regional Commercial Prioritization
TABLE 424: U.S. Smart Patient Monitoring Devices Market: Scope Limitation
TABLE 425: U.S. Smart Patient Monitoring Devices Market: Data Use Limitation
TABLE 426: U.S. Smart Patient Monitoring Devices Market: Market Sizing and Forecasting Limitation
TABLE 427: U.S. Smart Patient Monitoring Devices Market: Regulatory and Reimbursement Information Limitation
TABLE 428: U.S. Smart Patient Monitoring Devices Market: Legal Disclaimer
TABLE 429: U.S. Smart Patient Monitoring Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Smart Patient Monitoring Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Framework
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Hospital Capital Procurement Decision Framework
FIGURE 13: Remote Monitoring Reimbursement Economics Framework
FIGURE 14: Patient Engagement and Device Adherence Framework
FIGURE 15: U.S. Smart Patient Monitoring Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 16: U.S. Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 17: U.S. Smart Patient Monitoring Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 18: Device Type Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Device Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Wearable Biosensors and Smart Patches Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Smart Multiparameter, Bedside, and Transport Monitors Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Smart Glucose Monitoring Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Connected Cardiac Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Smart Respiratory and Specialty Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Monitoring Modality Segment Market Share Analysis, 2025 & 2035
FIGURE 26: Monitoring Modality Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Continuous Non-Invasive Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Remote Home-Based Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Ambulatory Wearable Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Intermittent and Connected Spot-Check Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Implantable Continuous Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 33: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Cardiac and Vascular Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Diabetes and Metabolic Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Respiratory Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Critical Care, Perioperative, and Post-Acute Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Neurological, Sleep, Maternal, Pediatric, and Other Specialty Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 40: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Home Healthcare, Virtual Care, and Remote Monitoring Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Ambulatory Clinics, Specialty Practices, and Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Skilled Nursing, Rehabilitation, and Long-Term Care Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Diagnostic Centers, Emergency Medical Services, and Telehealth Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 47: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Group Purchasing Organization and Distributor Channels Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Ambulatory, Physician Group, and Specialty Practice Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Remote Monitoring Platform and Care Management Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Pharmacy, Retail, and Consumer-Accessible Medical Device Channels Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: West Region U.S. Smart Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 57: West Region Market Share Analysis by State, 2025
FIGURE 58: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: California Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Washington Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Arizona Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Colorado Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Oregon Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Utah Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Nevada Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: New Mexico Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Idaho Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Montana Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Wyoming Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Alaska Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Hawaii Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Northeast Region U.S. Smart Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 73: Northeast Region Market Share Analysis by State, 2025
FIGURE 74: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New York Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Massachusetts Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New Jersey Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Pennsylvania Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Connecticut Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Maine Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Vermont Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: New Hampshire Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Rhode Island Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: South Region U.S. Smart Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 85: South Region Market Share Analysis by State, 2025
FIGURE 86: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Texas Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Florida Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Georgia Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: North Carolina Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Tennessee Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: South Carolina Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Alabama Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Mississippi Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Louisiana Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Arkansas Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Kentucky Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Oklahoma Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Virginia Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Maryland Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: West Virginia Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Delaware Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: District of Columbia Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Midwest Region U.S. Smart Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 105: Midwest Region Market Share Analysis by State, 2025
FIGURE 106: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Illinois Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Ohio Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Michigan Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Minnesota Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Indiana Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Wisconsin Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Missouri Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Iowa Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Kansas Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Nebraska Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: North Dakota Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: South Dakota Smart Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 120: Company Positioning Matrix
FIGURE 121: Key Player Product Portfolio and Care-Setting Benchmarking
FIGURE 122: Strategic Developments, Partnerships, M&A, Regulatory Clearances and Product Launches
FIGURE 123: Innovation Pipeline and Emerging Competitor Watchlist
FIGURE 124: Smart Patient Monitoring Device Innovation Roadmap
FIGURE 125: AI-Assisted Deterioration Detection and Predictive Monitoring Roadmap
FIGURE 126: Next-Generation Wearable Biosensor and Smart Patch Opportunity Map
FIGURE 127: Continuous Glucose and Multimodal Metabolic Monitoring Roadmap
FIGURE 128: Hospital-at-Home, Virtual Ward, and Command Center Growth Roadmap
FIGURE 129: Ambient, Contactless, and Camera-Based Monitoring Opportunity Map
FIGURE 130: Future Market Scenario Analysis, 2026–2035
FIGURE 131: Disruptive Technologies Impact Matrix
FIGURE 132: Emerging Business Trends Matrix
FIGURE 133: Investment Prioritization Matrix
FIGURE 134: Strategic Growth Roadmap for U.S. Smart Patient Monitoring Device Companies
FIGURE 135: Go-to-Market Strategy Framework
FIGURE 136: Product Positioning and Portfolio Expansion Framework
FIGURE 137: Interoperability, Cybersecurity, and Implementation Framework
FIGURE 138: Report Scope and Disclaimer Framework